Continuing Education

Join the RESPTREC® family for lifelong learning opportunities and mentorship.

CCCEP Logo

CCCEP: The Education, COPD and Asthma courses have been accredited by Canadian Council on Continuing Education in Pharmacy. Pharmacists have been involved in development of the curricula and review of the content.

The Canadian Council on Continuing Education in Pharmacy has confirmed accreditation as follows:

  • Asthma Management Course - 17.5 CEUs
  • COPD Management Course - 21.5 CEUs
  • Education for Chronic Disease Management Course - 27.5 CEUs

Resources: Download or order RESPTREC® resources:

  • Asthma Medications Brochure
  • COPD Medications Brochure
  • Delivery Device Instructions
  • Delivery Device Mastery Sheets
  • Inhaler Device Demonstration Videos

Webinars: Webinars on the most recent research, position papers, guidelines, topics are presented by leading experts in the field quarterly. 20-25 sites across western Canada participate. For those graduates who are unable to join a live session can access the presentations on-line, following the Webinar. Questions are posted following viewing of the presentation and a continuing education certificate can be printed for your records.


Current News

For your convenience RESPTREC® provides links to research articles, announcements, studies and other news updates which are posted daily onto the website. Reading these articles can be used towards recertification and continuing education.

Watch for upcoming opportunities!

Airflow limitation in people living with HIV and matched uninfected controls
May 15, 2018

HIV is a risk factor for concurrently decreased FEV1 and FVC. This excess risk is not explained by smoking or socioeconomic status and may be mediated by prior immunodeficiency.


Airway responsiveness to methacholine and incidence of COPD
May 15, 2018

This study suggests that increased airway responsiveness is an independent risk factor for COPD. Further research should clarify whether early treatment in patients with high responsiveness can slow down disease progression.


Improving the global diagnosis and management of asthma in children
May 15, 2018

This overview presents a first step for those involved in the diagnosis and management of childhood asthma to strengthen care for children globally.


Smoking duration alone provides stronger risk estimates of COPD than pack-years
May 15, 2018

Smoking duration alone provides stronger risk estimates of COPD than the composite index of pack-years


Home Oxygen in Chronic Obstructive Pulmonary Disease
May 15, 2018

This review article discusses the indicatoins and prescription of long-term oxygen therapy in patients with COPD


Clinical Knowledge from Observational Studies
May 13, 2018

This article concludes that observational research is a valuable source of medical evidence and that clinical action is strongest when supported by both high quality observational studies and randomized trials


The projected economic and health burden of sub-optimal asthma control in Canada
May 09, 2018

Sub-optimal asthma control is associated with a substantial economic and health burden. Given that with evidence-based disease management asthma can be controlled in the majority of patients, strategies towards improving asthma management can be associated with a significant return on investment.


Vitamin D in Asthma
May 06, 2018

There is increasing interest in the therapeutic utility of vitamin D in asthma, which is supported by a significant body of evidence on epidemiologic associations between vitamin D insufficiency and worse asthma control.


Clinical and Safety Outcomes of Long-Term Azithromycin Therapy in Severe COPD
May 06, 2018

Long-term continuous cyclic azithromycin  therapy ln severe COPD  achieved sustained reductions in exacerbations and hospitalizations of > 50% with few adverse events, although macrolide resistance increased.


Tai Chi and Pulmonary Rehabilitation
May 06, 2018

Tai Chi is equivalent to PR for improving SGRQ in COPD. Twelve weeks after exercise cessation, a clinically significant difference in SGRQ emerged favoring Tai Chi. Tai Chi is an appropriate substitute for PR.


Defining the “Frequent Exacerbator” Phenotype in COPD
May 06, 2018

These analyses confirmed the existence and clinical relevance of a frequent exacerbator subgroup of patients with COPD and the currently used threshold to define this phenotype.


Gait Speed: Validity of Measurement in Patients With Severe Chronic Lung Disease
May 06, 2018

Gait speed is used increasingly to predict function and future well-being among healthy elderly people as well as for those with long-term medical conditions.


Paediatric Asthma
May 03, 2018

This Monograph covers all aspects of paediatric asthma, across all ages, from birth through to the start of adulthood. It considers diagnostic problems in relation to the many phenotypes of asthma, covers the treatment of both mild-to-moderate and severe asthma, and discusses asthma exacerbations as well as exercise-induced asthma. In…


Personalised medicine in interstitial lung diseases
May 03, 2018

ILDs in general, and IPF in particular, are complex disorders with multiple pathogenetic pathways, various disease behaviour profiles and differential responses to treatment, all facets that make personalised medicine a highly attractive concept.


Age, risk and outcomes in idiopathic pulmonary arterial hypertension
May 03, 2018

The likelihood that  idiopathic pulmonary arterial hypertension patients meet a low risk profile with targeted therapies diminishes with increasing age. Almost 80% of patients age 18-45 reached the low risk category with PAH treatment, compared with 20% aged ≥65 


© 2018 The Lung Association of Saskatchewan, Inc.
All Rights Reserved.

1231 8th St E
Saskatoon, SK
S7H 0S5
  • Twitter
  • Facebook

Presented By

CNRC Approved Educator Program
CNRC

RESPTREC® Advance your skills. Be a leader.™

Privacy Statement & Disclaimer.

CCCEP Accredited